LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION April 6, 2023 TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB301 by Hall (relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources. Local Government ImpactNo significant fiscal implication to units of local government is anticipated. Source Agencies: b > td > 503 Texas Medical Board, 515 Board of Pharmacy LBB Staff: b > td > JMc, NPe, SLee
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
April 6, 2023
TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: SB301 by Hall (relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.), Committee Report 1st House, Substituted
TO: Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: SB301 by Hall (relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.), Committee Report 1st House, Substituted
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
SB301 by Hall (relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.), Committee Report 1st House, Substituted
SB301 by Hall (relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 503 Texas Medical Board, 515 Board of Pharmacy
503 Texas Medical Board, 515 Board of Pharmacy
LBB Staff: b > td > JMc, NPe, SLee
JMc, NPe, SLee